Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Enoxaparin Sodium prices in Germany, the highest-cost reporting region, rose 3.0% in Q2 2026 to USD 51,000.00/KG from USD 49,500.00/KG in Q1, extending a sharp reversal from the gradual multi-quarter decline that had characterized this market through most of 2025. US prices rose 2.9% to USD 46,400.00/KG, tracking the same feedstock-driven firming trend evident across every region tracked in this report. Globally, the average rose from USD 40,140.00/KG in Q1 to USD 41,336.00/KG in Q2, a 3.0% gain, following a jump of 9.9% in Q1 alone as elevated porcine heparin feedstock costs reversed the earlier softening trend. For H2 2026, a global average of USD 33,500.00-52,500.00/KG is expected, with elevated feedstock costs likely to keep this market firm.
Enoxaparin Sodium is a low molecular weight heparin anticoagulant active pharmaceutical ingredient, produced through the controlled enzymatic or chemical depolymerization of unfractionated heparin derived from porcine intestinal mucosa. It is used in the prevention and treatment of deep vein thrombosis, pulmonary embolism, and acute coronary syndromes, administered via subcutaneous injection in both hospital and outpatient settings. Because its raw material, crude heparin, is sourced from a biological byproduct of pork processing operations concentrated in a limited number of countries, this market's supply availability is tightly linked to global pig slaughter volumes and heparin extraction capacity, a structural constraint that has periodically caused sharp feedstock cost swings independent of broader petrochemical market conditions. Porcine heparin feedstock costs, hospital and outpatient anticoagulant treatment demand, and regional generic API manufacturing capacity are what drive prices in this market.
The outlook for Enoxaparin Sodium through H2 2026 stays firm, tracking elevated porcine heparin feedstock costs tied to global pig slaughter volumes and extraction capacity constraints. Steady demand from hospital and outpatient anticoagulant treatment channels, tied to deep vein thrombosis and acute coronary syndrome management, should continue supporting consumption even as the pace of further gains likely moderates from the sharp Q1 2026 spike that characterized every region covered here.
The main upside risk is a further tightening of porcine heparin feedstock availability, tied to reduced pig slaughter volumes or extraction capacity constraints in major sourcing countries, which would push production costs higher across every region. The main downside risk is a faster-than-expected normalization of feedstock costs combined with intensifying generic competition, which would ease some of the current price pressure.
| Region | 2026 Price Range (USD/KG) | Outlook |
| Global Average | 33,500.00 - 52,500.00 | Elevated feedstock costs keep this market firm |
| Germany | 44,000.00 - 51,000.00 | Established European formulator base sustains the highest cost |
| United States | 40,500.00 - 47,500.00 | Steady hospital anticoagulant demand supports continued firmness |
| India | 31,000.00 - 36,500.00 | Growing generic API production drives continued gains |
| China | 27,000.00 - 32,000.00 | Large-scale API production capacity keeps this the most affordable market |
German Enoxaparin Sodium prices averaged USD 51,000.00/KG in Q2 2026, the highest of any region tracked here, up 3.0% from USD 49,500.00/KG in Q1, as this market's established European formulator base continued sustaining the premium through the quarter. These conditions are expected to remain a key factor shaping pricing in the near term. Buyers and sellers alike watched these developments closely for signs of further movement.
Why did the price of Enoxaparin Sodium change in Q2 2026 in Germany?
Steady demand from established European formulators, tied to hospital and outpatient anticoagulant prescribing channels, continued keeping this market at the top of the range tracked in this report through the quarter. Regional supply and demand balances continued to evolve as the quarter progressed. These conditions are expected to remain a key factor shaping pricing in the near term. These conditions are expected to remain a key factor shaping pricing in the near term.
US prices averaged USD 46,400.00/KG in Q2 2026, up 2.9% from USD 45,100.00/KG in Q1, as steady demand from hospital anticoagulant treatment providers continued supporting this market through the quarter. Regional supply and demand balances continued to evolve as the quarter progressed. These conditions are expected to remain a key factor shaping pricing in the near term. Regional supply and demand balances continued to evolve as the quarter progressed.
Why did the price of Enoxaparin Sodium change in Q2 2026 in United States?
Consistent demand from hospital anticoagulant treatment providers, tied to deep vein thrombosis and acute coronary syndrome management, kept US buyers active even as porcine heparin feedstock costs continued moving higher through the quarter. Buyers and sellers alike watched these developments closely for signs of further movement. Regional supply and demand balances continued to evolve as the quarter progressed. Regional supply and demand balances continued to evolve as the quarter progressed.
Indian prices averaged USD 34,600.00/KG in Q2 2026, up 3.0% from USD 33,600.00/KG in Q1, as growing demand from India's expanding generic anticoagulant API manufacturing sector continued driving gains. Buyers and sellers alike watched these developments closely for signs of further movement. Regional supply and demand balances continued to evolve as the quarter progressed. Buyers and sellers alike watched these developments closely for signs of further movement.
Why did the price of Enoxaparin Sodium change in Q2 2026 in India?
Continued growth in demand from India's expanding generic anticoagulant API manufacturing sector kept buyers competing for available heparin-derived synthesis intermediates, supporting continued price gains through the quarter. These conditions are expected to remain a key factor shaping pricing in the near term. Buyers and sellers alike watched these developments closely for signs of further movement. Buyers and sellers alike watched these developments closely for signs of further movement.
Chinese prices, the lowest of the four regions, averaged USD 30,400.00/KG in Q2 2026, up 3.1% from USD 29,500.00/KG in Q1, as large-scale domestic API production capacity continued keeping this market comparatively affordable. These conditions are expected to remain a key factor shaping pricing in the near term. Buyers and sellers alike watched these developments closely for signs of further movement.
Why did the price of Enoxaparin Sodium change in Q2 2026 in China?
Large-scale domestic API production capacity continued keeping Chinese offers the most competitive of any region tracked here, even as the broader porcine heparin feedstock cost environment pushed prices modestly higher through the quarter. Regional supply and demand balances continued to evolve as the quarter progressed. These conditions are expected to remain a key factor shaping pricing in the near term.
German prices surged 10.0% in Q1 2026 to USD 49,500.00/KG from USD 45,000.00/KG in Q4 2025, as porcine heparin feedstock costs spiked following tighter global pig slaughter volumes and extraction capacity constraints. Buyers and sellers alike watched these developments closely for signs of further movement. Regional supply and demand balances continued to evolve as the quarter progressed. These conditions are expected to remain a key factor shaping pricing in the near term.
Why did the price of Enoxaparin Sodium change in Q1 2026 in Germany?
Porcine heparin feedstock prices surged sharply as global pig slaughter volumes tightened and extraction capacity constraints raised the cost basis across the entire anticoagulant API value chain, and that pressure flowed directly through to finished enoxaparin sodium pricing across German formulator supply chains. These conditions are expected to remain a key factor shaping pricing in the near term. Buyers and sellers alike watched these developments closely for signs of further movement.
US prices surged 10.0% in Q1 2026 to USD 45,100.00/KG from USD 41,000.00/KG in Q4 2025, tracking the broader feedstock cost spike affecting heparin-derived API production economics. These conditions are expected to remain a key factor shaping pricing in the near term. Buyers and sellers alike watched these developments closely for signs of further movement. Regional supply and demand balances continued to evolve as the quarter progressed.
Why did the price of Enoxaparin Sodium change in Q1 2026 in United States?
Elevated porcine heparin feedstock costs, tied to global pig slaughter volume constraints, pushed US production expenses sharply higher, even as steady underlying hospital anticoagulant treatment demand kept this market fundamentally well supported. Regional supply and demand balances continued to evolve as the quarter progressed. These conditions are expected to remain a key factor shaping pricing in the near term. Regional supply and demand balances continued to evolve as the quarter progressed.
Indian prices surged 9.8% in Q1 2026 to USD 33,600.00/KG from USD 30,600.00/KG in Q4 2025, tracking the broader global porcine heparin feedstock cost spike. Regional supply and demand balances continued to evolve as the quarter progressed. These conditions are expected to remain a key factor shaping pricing in the near term. Buyers and sellers alike watched these developments closely for signs of further movement.
Why did the price of Enoxaparin Sodium change in Q1 2026 in India?
Elevated porcine heparin feedstock prices, following tighter global extraction capacity and pig slaughter volumes, increased production costs for anticoagulant API manufacturers, pushing Indian enoxaparin sodium prices higher through the quarter. Buyers and sellers alike watched these developments closely for signs of further movement. Regional supply and demand balances continued to evolve as the quarter progressed. Buyers and sellers alike watched these developments closely for signs of further movement.
Chinese prices surged 9.7% in Q1 2026 to USD 29,500.00/KG from USD 26,900.00/KG in Q4 2025, tracking the global heparin feedstock cost spike even as domestic production capacity remained substantial. Buyers and sellers alike watched these developments closely for signs of further movement. Regional supply and demand balances continued to evolve as the quarter progressed. These conditions are expected to remain a key factor shaping pricing in the near term.
Why did the price of Enoxaparin Sodium change in Q1 2026 in China?
Rising porcine heparin feedstock costs, tied to the broader global supply constraint affecting crude heparin sourcing, fed through to Chinese enoxaparin sodium pricing even as the country's substantial domestic production capacity kept the pace of the increase comparatively moderate. These conditions are expected to remain a key factor shaping pricing in the near term. Buyers and sellers alike watched these developments closely for signs of further movement.
Global Enoxaparin Sodium prices eased gradually through most of 2025 as porcine heparin feedstock costs moderated, before accelerating sharply in Q1 2026 as tighter global pig slaughter volumes and extraction capacity constraints pushed prices to their highest levels of the period, a trend that continued into Q2 across every region tracked in this report. Regional supply and demand balances continued to evolve as the quarter progressed.
| Quarter | Price (USD/KG) | QoQ Change | Direction |
| Q2 2026 | 41,336.00 | +3.0% | ↑ Rising |
| Q1 2026 | 40,140.00 | +9.9% | ↑ Rising |
| Q4 2025 | 36,522.00 | -2.4% | ↓ Falling |
| Q3 2025 | 37,408.00 | -2.3% | ↓ Falling |
| Q2 2025 | 38,294.00 | - | — Stable |
| Q3 2026 | In Progress | - | — In Progress |
Enoxaparin Sodium eased across every market covered in this report through 2025, tracking moderating porcine heparin feedstock costs, before tighter global pig slaughter volumes and extraction capacity constraints sharply reversed that trend in Q1 2026, pushing feedstock costs, and with them anticoagulant API production economics, higher across every region tracked here. Buyers and sellers alike watched these developments closely for signs of further movement.
German prices eased from about USD 48,000.00/KG in Q1 2025 to USD 45,000.00/KG by Q4, down roughly 6.3%, before the sharp Q1 2026 reversal that followed as porcine heparin feedstock costs spiked. Regional supply and demand balances continued to evolve as the quarter progressed. These conditions are expected to remain a key factor shaping pricing in the near term. These conditions are expected to remain a key factor shaping pricing in the near term.
US prices eased from about USD 44,000.00/KG in Q1 2025 to USD 41,000.00/KG by Q4, down roughly 6.8%, the steepest annual decline of the four regions before the sharp reversal that followed into 2026. Buyers and sellers alike watched these developments closely for signs of further movement. Regional supply and demand balances continued to evolve as the quarter progressed. Regional supply and demand balances continued to evolve as the quarter progressed.
Indian prices eased from about USD 33,000.00/KG in Q1 2025 to USD 30,600.00/KG by Q4, down roughly 7.3%, tracking the broader moderating feedstock cost trend through most of the year before the reversal that followed. These conditions are expected to remain a key factor shaping pricing in the near term. Buyers and sellers alike watched these developments closely for signs of further movement.
Chinese prices eased from about USD 29,000.00/KG in Q1 2025 to USD 26,900.00/KG by Q4, down roughly 7.2%, the smallest annual decline of the four regions, before the sharp reversal that followed once feedstock costs spiked. Regional supply and demand balances continued to evolve as the quarter progressed. These conditions are expected to remain a key factor shaping pricing in the near term.
Expert Market Research: Your Source for Real-Time Enoxaparin Sodium Price Intelligence
Expert Market Research tracks Enoxaparin Sodium prices continuously across every major producing and consuming region, combining porcine heparin feedstock cost data, hospital and outpatient anticoagulant treatment demand signals, and regional generic API manufacturing capacity trends into a single, regularly updated view of the market. Our team can help your procurement function benchmark current offers, plan purchases around the sharp reversal covered in this report, and build a defensible view of where this essential anticoagulant API is headed next. Reach out to our team for a tailored briefing or a deeper look at any of the regional markets covered here.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
It is a low molecular weight heparin anticoagulant used to prevent and treat deep vein thrombosis, pulmonary embolism, and acute coronary syndromes.
The Q2 2026 global average was USD 41,336.00/KG, ranging from USD 30,400.00/KG in China to USD 51,000.00/KG in Germany.
The global average rose from USD 36,522.00/KG in Q4 2025 to USD 40,140.00/KG in Q1 2026 and then to USD 41,336.00/KG in Q2.
Its raw material, crude heparin, is sourced from porcine intestinal mucosa, tying supply to global pig processing volumes.
The global average is expected in the USD 33,500.00-52,500.00/KG range, with elevated feedstock costs keeping this market firm.
China holds the lowest cost given large-scale API production, while Germany carries the highest cost given its established formulator base.
This report is updated monthly. Connect with the Expert Market Research team for real-time pricing.
Porcine heparin feedstock costs, hospital anticoagulant demand, and regional generic API manufacturing capacity.
China and India maintain substantial generic API manufacturing capacity tied to their crude heparin sourcing base.
Buyers can monitor porcine heparin feedstock costs, and benchmark quotes against this report's ranges.
One Year Subscription
One Year Subscription
USD 799
USD 699
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.